Author
Listed:
- Antonio Drago
(Institute of Psychiatry, University of Bologna, Italy)
- Ioannis Liappas
(Department of Psychiatry, Eginition Hospital, University of Athens Medical School, Athens, Greece)
- Carmine Petio
(Institute of Psychiatry, University of Bologna, Italy
Department of Mental Health, Azienda USL di Bologna, Bologna, Italy)
- Diego Albani
(Neuroscience Department. Istituto di ricerche Farmacologiche "Mario Negri", Milan, Italy)
- Gianluigi Forloni
(Neuroscience Department. Istituto di ricerche Farmacologiche "Mario Negri", Milan, Italy)
- Petros Malitas
(European Centre for the Quality of Life – E.C.Qua.L., Athens, Greece)
- Christina Piperi
(Laboratory of Biological Chemistry University of Athens Medical School, Greece)
- Antonis Politis
(Division of Geriatric Psychiatry Department of Psychiatry, Eginition Hospital, University of Athens Medical School, Athens, Greece)
- Elias O. Tzavellas
(Department of Psychiatry, Eginition Hospital, University of Athens Medical School, Athens, Greece)
- Katerina K. Zisaki
(Department of Pharmacology, University of Athens Medical School, Athens, Greece)
- Francesca Prato
(Neuroscience Department. Istituto di ricerche Farmacologiche "Mario Negri", Milan, Italy)
- Sara Batelli
(Neuroscience Department. Istituto di ricerche Farmacologiche "Mario Negri", Milan, Italy)
- Letizia Polito
(Neuroscience Department. Istituto di ricerche Farmacologiche "Mario Negri", Milan, Italy)
- Diana De Ronchi
(Institute of Psychiatry, University of Bologna, Italy)
- Thomas Paparrigopoulos
(Department of Psychiatry, Eginition Hospital, University of Athens Medical School, Athens, Greece)
- Anastasios Kalofoutis
(European Centre for the Quality of Life – E.C.Qua.L., Athens, Greece
Laboratory of Biological Chemistry University of Athens Medical School, Greece
Biomedical Research Foundation of Academy of Athens, Greece)
- Alessandro Serretti
(Institute of Psychiatry, University of Bologna, Italy)
Abstract
We assessed a set of biological (HDL, LDL, SGOT,SGPT, GGT, HTc, Hb and T levels) and psychometric variables (investigated through HAM-D, HAM-A, GAS, Liebowitz Social Anxiety Scale, Mark & Mathews Scale, Leyton scale, and Pilowski scale) in a sample of 64 alcohol dependent patients, at baseline and after a detoxification treatment. Moreover, we recruited 47 non-consanguineous relatives who did not suffer alcohol related disorders and underwent the same tests. In both groups we genotyped 11 genetic variations (rs1800587; rs3087258; rs1799724; 5-HTTLPR ; rs1386493; rs1386494; rs1487275; rs1843809; rs4570625; rs2129575; rs6313) located in genes whose impact on alcohol related behaviors and disorders has been hypothesized ( IL1A , IL1B , TNF , 5-HTTLPR , TPH2 and HTR2A ). We analyzed the epistasis of these genetic variations upon the biological and psychological dimensions in the cases and their relatives. Further on, we analyzed the effects of the combined genetic variations on the short – term detoxification treatment efficacy. Finally, being the only not yet investigated variation within this sample, we analyzed the impact of the rs6313 alone on baseline assessment and treatment efficacy. We detected the following results: the couple rs6313 + rs2129575 affected the Leyton -Trait at admission (p = 0.01) (obsessive-compulsive trait), whilst rs1800587 + 5-HTTLPR impacted the Pilowski test at admission (p = 0.01) (hypochondriac symptoms). These results did not survive Bonferroni correction (p ≤ 0.004). This lack of association may depend on the incomplete gene coverage or on the small sample size which limited the power of the study. On the other hand, it may reflect a substantial absence of relevance of the genotype variants toward the alcohol related investigated dimensions. Nonetheless, the marginal significance we detected could witness an informative correlation worth investigating in larger samples.
Suggested Citation
Antonio Drago & Ioannis Liappas & Carmine Petio & Diego Albani & Gianluigi Forloni & Petros Malitas & Christina Piperi & Antonis Politis & Elias O. Tzavellas & Katerina K. Zisaki & Francesca Prato & S, 2009.
"Epistasis between IL1A , IL1B , TNF , HTR2A , 5-HTTLPR and TPH2 Variations Does Not Impact Alcohol Dependence Disorder Features,"
IJERPH, MDPI, vol. 6(7), pages 1-11, July.
Handle:
RePEc:gam:jijerp:v:6:y:2009:i:7:p:1980-1990:d:5373
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:6:y:2009:i:7:p:1980-1990:d:5373. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.